Reframe Wealth’s Eli Lilly LLY Stock Holding History

Reframe Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$276K	Buy	+754	New	+$267K	0.11%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Reframe Wealth's LLY Position: Q4 2022 in Review

Reframe Wealth opened a new position in Eli Lilly (LLY) in Q4 2022: 754 shares worth $276K. The stake represents 0.11% of the portfolio and ranks #51 among its holdings.

2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

Reframe Wealth held 754 shares of Eli Lilly worth $276K as of Q4 2022.
Eli Lilly was a new Reframe Wealth position in Q4 2022.
Eli Lilly made up 0.11% of Reframe Wealth's portfolio in Q4 2022, its #51 holding.
2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Reframe Wealth's 13F filing for Q4 2022, filed 30 Mar 2023.